Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 96
Filter
1.
Angew Chem Int Ed Engl ; 63(12): e202319414, 2024 Mar 18.
Article in English | MEDLINE | ID: mdl-38295149

ABSTRACT

Efficient plastic recycling processes are crucial for the production of value-added products or intermediates. Here, we present a multicatalytic route that allows the degradation of nitrile-butadiene rubber, cross-metathesis of the formed oligomers, and polymerization of the resulting dicarboxylic acids with bio-based diols, providing direct access to unsaturated polyesters. This one-pot approach combines the use of commercially available catalysts that are active and selective under mild conditions to synthesize renewable copolymers without the need to isolate intermediates.

2.
Eur J Obstet Gynecol Reprod Biol ; 293: 95-105, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38134610

ABSTRACT

For patients with endometrioma it is unclear what treatment: surgery and/or medication, is more effective in reducing pain and improving quality of life (QoL). This systematic review and meta- analysis aimed to provide an overview of the existing evidence on the effects of surgery and/or medication (i.e. analgesics and/or hormonal medication) on pain and QoL. A search through CENTRAL, MEDLINE and Embase was conducted. The study population had to be women treated for endometrioma. Retrospective or prospective studies reporting about QoL and/or the following types of pain were reviewed: dysmenorrhea, dyspareunia, chronic pelvic pain, and pain that was not well defined in the included article (referred to as pain). We performed a meta-analysis on mean visual analogue scale (VAS) scores and proportions of patients experiencing different types of pain over time. QoL was described narratively. Out of 11.515 articles, 76 studies including 7148 patients were included for the systematic review. The meta-analysis consisted of 52 studies including 4556 patients. No studies compared medication with surgery. And there were no studies on analgesics. Meta-analysis showed that surgery and/or medication often reduced VAS scores and proportions of all types of pain over time. Surgery and medication combined seems more effective in reducing VAS scores of pain compared to surgery alone, but not to medication alone (estimated mean difference = 0.17, p < 0.0001 and -0.98, p = 0.0339). QoL improved after medication (follow up ≤ 12 months) and QoL was unchanged or worsened after surgery and medication combined (follow up ≤ 24 months). However, these were results from a total of 5 studies. Both surgery and medication reduce endometriosis-related pain in patients with endometrioma. However, there is lack of uniform, good quality data comparing surgery with medication to draw firm conclusions. For better-informed treatment decisions, further studies including a standardized core-outcome set at fixed follow-up times, are necessary.


Subject(s)
Endometriosis , Humans , Female , Endometriosis/complications , Endometriosis/drug therapy , Endometriosis/surgery , Quality of Life , Prospective Studies , Retrospective Studies , Pelvic Pain/drug therapy , Pelvic Pain/etiology , Analgesics/therapeutic use
3.
Molecules ; 27(13)2022 Jun 24.
Article in English | MEDLINE | ID: mdl-35807313

ABSTRACT

The most versatile furanic building block for chemical and polymer applications is 2,5-furandicarboxylic acid. However, the classical 2,5-furandicarboxylic acid production methodology has been found to have significant drawbacks that hinder industrial-scale production. This review highlights new alternative methods to synthesize 2,5-furandicarboxylic acid that are both more advantageous and attractive than conventional oxidation of 5-hydroxymethylfurfural. This review also focuses on the use of 2,5-furandicarboxylic acid as a polymer precursor and the various potential applications that arise from these furan-based materials.


Subject(s)
Dicarboxylic Acids , Polymers , Furans , Oxidation-Reduction
4.
Chem Soc Rev ; 50(24): 13587-13608, 2021 Dec 13.
Article in English | MEDLINE | ID: mdl-34786575

ABSTRACT

This review highlights recent developments in the field of biodegradable polymeric materials intended to replace non-degradable conventional plastics, focusing on studies from the last ten years involving the stereoselective ring-opening polymerization of cyclic esters. This encompasses exciting advances in both catalyst design and monomer scope. Notably, the last decade has seen the emergence of metal-free stereocontrolled ROP for instance, as well as the synthesis and stereocontrolled polymerization of new types of chiral monomers. This study will emphasize recent stereoselective polymerization catalysts and chiral monomers and will focus on stereocontrol quantification, the mechanisms of stereocontrol and their differentiation if reported and studied for a specific catalyst system.


Subject(s)
Polyesters , Polymers , Catalysis , Esters , Polymerization
5.
Dalton Trans ; 50(29): 10067-10081, 2021 Jul 27.
Article in English | MEDLINE | ID: mdl-34195731

ABSTRACT

Neutral and ionic ruthenium and iron aliphatic PNHP-type pincer complexes (PNHP = NH(CH2CH2PiPr2)2) bearing benzyl, n-butyl or tert-butyl isocyanide ancillary ligands have been prepared and characterized. Reaction of [RuCl2(PNHP)]2 with one equivalent CN-R per ruthenium center affords complexes [RuCl2(PNHP)(CNR)] (R = benzyl, 1a, R = n-butyl, 1b, R = t-butyl, 1c), with cationic [RuCl(PNHP)(CNR)2]Cl 2a-c as side-products. Dichloride species 1a-c react with excess NaBH4 to afford [RuH(PNHP)(BH4)(CN-R)] 3a-c, analogues to benchmark Takasago catalyst [RuH(PNHP)(BH4)(CO)]. Reaction of 1a-c with a single equivalent of NaBH4 results in formation of [RuHCl(PNHP) (CN-R)] (4a-c), from which 3a-c can be prepared upon reaction with excess NaBH4. Use of one equivalent of NaHBEt3 with 4a and 4c affords bishydrides [Ru(H)2(PNHP)(CN-R)] 5a and 5c. Deprotonation of 4c by KOtBu generates amido derivative [RuH(PNP)(CN-t-Bu)] (6, PNP = -N(CH2CH2PiPr2)2), unstable in solution. Addition of excess benzylisonitrile to 4a provides cationic hydride [RuH(PNHP) (CN-CH2Ph)2]Cl (7). Concerning iron chemistry, [Fe(PNHP)Br2] reacts with one equivalent of benzylisonitrile to afford [FeBr(PNHP)(CNCH2Ph)2]Br (8). The outer-sphere bromide anion can be exchanged by salt metathesis with NaBPh4 to generate [FeBr(PNHP) (CNCH2Ph)2](BPh4) (9). Cationic hydride species [FeH(PNHP) (CN-t-Bu)2](BH4) (10) is prepared from consecutive addition of excess CN-t-Bu and NaBH4 on [Fe(PNPH)Br2]. Ruthenium complexes 3a-c are active in acceptorless alcohol dehydrogenative coupling into ester under base-free conditions. From kinetic follow-up, the trend in initial activity is 3a ≈ 3b > [RuH(PNHP)(BH4)(CO)] ≫ 3c; for robustness, [RuH(BH4)(CO)(PNHP)] > 3a > 3b ≫ 3c. Hypotheses are given to account for the observed deactivation. Complexes 3b, 3c, 4a, 4c, 5c, 7, cis-8 and 9 were characterized by X-ray crystallography.

6.
J Magn Reson ; 330: 107029, 2021 09.
Article in English | MEDLINE | ID: mdl-34311423

ABSTRACT

The measurement of dipolar and J- couplings between 29Si and 17O isotopes is challenging owing to (i) the low abundance of both isotopes and (ii) their close Larmor frequencies, which only differ by 19%. These issues are circumvented here by the use of isotopic enrichment and dedicated triple-resonance magic-angle spinning NMR probe. The surface of 29Si-enriched silica was labelled with 17O isotope and heated at 80 and 200 °C. 29Si-17O connectivities and proximities were probed using two-dimensional (2D) through-bond and through-space heteronuclear multiple-quantum coherences (J- and D-HMQC) experiments between 17O and 29Si nuclei. The simulation of the build-up of the J- and D-HMQC signals allowed the first experimental measurement of J- and dipolar coupling constants between 17O and 29Si nuclei. These HMQC experiments allow distinguishing two distinct siloxane (SiOSi) oxygen sites: (i) those covalently bonded to Q3 and Q4 groups, having a hydroxyl group as a second neighbour and (ii) those covalently bonded to two Q4 groups. The measured J- and dipolar coupling constants of siloxane 17O nucleus with Q4 29Si nuclei differ from those with Q3 29Si nuclei. These results indicate that the 29Si-17O one-bond J-coupling and Si-O bond length depend on the second neighbours of the Si atoms.

7.
Front Pain Res (Lausanne) ; 2: 692250, 2021.
Article in English | MEDLINE | ID: mdl-35295530

ABSTRACT

Fibromyalgia (FM) is a complex pain syndrome accompanied by physical disability and loss of daily life activities. Evidences suggest that modulation of the primary motor cortex (M1) by transcranial direct current stimulation (tDCS) improves functional physical capacity in chronic pain conditions. However, the gain on physical function in people living with FM receiving tDCS is still unclear. This study aimed to evaluate whether the tDCS task-oriented approach improves function and reduces pain in a single cohort of 10 FM. A total of 10 women with FM (60.4 ± 15.37 years old) were enrolled in an intervention including anodal tDCS delivered on M1 (2 mA from a constant stimulator for 20 min); simultaneously they performed a functional task. The anode was placed on the contralateral hemisphere of the dominant hand. Outcome assessments were done before the stimulation, immediately after stimulation and 30 min after the end of tDCS. The same protocol was applied in subsequent sessions. A total of five consecutive days of tDCS were completed. The main outcomes were the number of repetitions achieved and time in active practice to evaluate functional physical task performance such as intensity of the pain (visual analog scale) and level of fatigue (Borg scale). After 5 days of tDCS, the number of repetitions achieved significantly increased by 49% (p = 0.012). No change was observed in active practice time. No increase in pain was observed despite the mobility of the painful parts of the body. These results are encouraging since an increase in pain due to the mobilization of painful body parts could have been observed at the end of the 5th day of the experiment. These results support the use of tDCS in task-based rehabilitation.

8.
Immunology ; 162(3): 290-305, 2021 03.
Article in English | MEDLINE | ID: mdl-33112414

ABSTRACT

Elevated frequency of Th17-like cells expressing Toll-like receptors (TLRs) has been recently associated with relapsing-remitting multiple sclerosis (MS) pathogenesis, a chronic inflammatory demyelinating autoimmune disease of the central nervous system. We aimed to investigate the impact of current major depressive disorder (MDD) on the behaviour of these cells following in vitro stimulation with TLR2, TLR4, TLR5 and TLR9 agonists. Here, the level of both cell proliferation and cytokine production related to Th17/Tc17 phenotypes in response to TLR2 (Pam3C) and TLR4 (LPS) ligands was significantly higher in CD4+ and CD8+ T-cell cultures from MS/MDD patients when compared to non-depressed patients. These cytokine levels were positively associated with neurological disabilities in patients. No difference for responsiveness to TLR5 (flagellin) and TLR9 (ODN) agonists was observed. LPS, but not Pam3C, induced significant IL-10 release, mainly in patients without MDD. Interestingly, more intense expression of TLR2 and TLR4 on these cells was observed in MDD patients. Finally, in vitro addition of serotonin and treatment of MDD patients with selective serotonin reuptake inhibitors (SSRIs) reduced the production of Th17/Tc17-related cytokines by CD4+ and CD8+ T cells in response to Pam3C and LPS. However, only SSRI therapy diminished the frequency and intensity of TLR2 and TLR4 expression on circulating CD4+ and CD8+ T cells. In summary, although preliminary, our findings suggest that adverse events that elevate circulating levels of TLR2 and TLR4 ligands can affect MS pathogenesis, particularly among depressed patients.


Subject(s)
Antidepressive Agents, Second-Generation/therapeutic use , CD8-Positive T-Lymphocytes/drug effects , Depressive Disorder, Major/drug therapy , Fluoxetine/therapeutic use , Lymphocyte Activation/drug effects , Multiple Sclerosis, Relapsing-Remitting/immunology , Selective Serotonin Reuptake Inhibitors/therapeutic use , Th17 Cells/drug effects , Toll-Like Receptor 2/metabolism , Toll-Like Receptor 4/metabolism , Adult , CD8-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/metabolism , Case-Control Studies , Cell Proliferation/drug effects , Cells, Cultured , Cytokines/metabolism , Depressive Disorder, Major/diagnosis , Depressive Disorder, Major/immunology , Depressive Disorder, Major/psychology , Female , Humans , Male , Middle Aged , Multiple Sclerosis, Relapsing-Remitting/diagnosis , Multiple Sclerosis, Relapsing-Remitting/metabolism , Phenotype , Th17 Cells/immunology , Th17 Cells/metabolism , Treatment Outcome , Young Adult
9.
Physiol Meas ; 41(11): 115002, 2020 12 11.
Article in English | MEDLINE | ID: mdl-33049730

ABSTRACT

OBJECTIVE: To investigate the effect of maternal hyperoxygenation on fetal heart rate (FHR) when applied for suspected fetal distress during the second stage of term labor. APPROACH: A single-center randomized controlled trial was conducted in a tertiary care hospital in The Netherlands. Participants were included during the second stage of labor in case of an intermediary or abnormal FHR pattern. Patients were randomized to receive either 100% oxygen at 10 l/min until delivery, or conventional care without additional oxygen. The primary outcome was the change in FHR pattern before and after the onset of the study, measured as the change in depth and duration of FHR decelerations. Secondary outcome measures were features based on phase-rectified signal averaging (PRSA), baseline assignability, and deceleration characteristics of the FHR pattern. MAIN RESULTS: Between March 2016 and April 2018, 117 women were included. The FHR pattern could be analyzed for 71 participants, the other 46 women delivered before the end of the post time-frame. A 2.3% reduction in depth and duration of FHR decelerations was found after maternal hyperoxygenation, compared to a 10% increase in the control group (p = 0.24). Maternal hyperoxygenation had a significantly positive effect on PRSA metrics, with a decrease in PRSA-acceleration capacity (p = 0.03) and PRSA-deceleration capacity (p = 0.02) in the intervention group compared to the control group. SIGNIFICANCE: The difference in depth and duration of decelerations after the start of the study was not significantly different between both study groups. A statistically significant positive effect on PRSA-deceleration capacity and PRSA-acceleration capacity was found after maternal hyperoxygenation, which might be associated with a positive effect on neonatal outcome.


Subject(s)
Fetal Distress , Heart Rate, Fetal , Labor, Obstetric , Oxygen/administration & dosage , Acceleration , Female , Humans , Infant, Newborn , Netherlands , Pregnancy , Tertiary Care Centers
10.
Phys Rev Lett ; 124(10): 101102, 2020 Mar 13.
Article in English | MEDLINE | ID: mdl-32216401

ABSTRACT

In recent years, many γ-ray sources have been identified, yet the unresolved component hosts valuable information on the faintest emission. In order to extract it, a cross-correlation with gravitational tracers of matter in the Universe has been shown to be a promising tool. We report here the first identification of a cross-correlation signal between γ rays and the distribution of mass in the Universe probed by weak gravitational lensing. We use data from the Dark Energy Survey Y1 weak lensing data and the Fermi Large Area Telescope 9-yr γ-ray data, obtaining a signal-to-noise ratio of 5.3. The signal is mostly localized at small angular scales and high γ-ray energies, with a hint of correlation at extended separation. Blazar emission is likely the origin of the small-scale effect. We investigate implications of the large-scale component in terms of astrophysical sources and particle dark matter emission.

11.
Am J Reprod Immunol ; 83(2): e13204, 2020 02.
Article in English | MEDLINE | ID: mdl-31674097

ABSTRACT

PROBLEM: Pregnancy appears to favor maternal antibody production. In contrast, by damaging follicular helper T cells (TFH ), HIV-1 infection compromises protective humoural immune response. Therefore, we aimed to investigate the frequency of different TFH -like cells in HIV-infected pregnant women (PW) before and after antiretroviral (ARV) therapy. METHOD OF STUDY: Peripheral blood mononuclear cells, CD4+ T and B cells, were obtained from asymptomatic HIV-1-infected non-PW and PW just before and after ARV therapy. In some experiments, healthy HIV-1-negative PW were also tested. The frequency of different TFH -like cell subsets was determined by flow cytometry. The plasma titers of IgG anti-tetanus toxoid (TT), anti-HBsAg, and anti-gp41 were determined by ELISA. The in vitro production of total IgG, IL-21, and hormones (estrogen and progesterone) was quantified also by ELISA. RESULTS: Our results demonstrate that antiretroviral (ARV) therapy was more efficient in elevating the percentage of circulating IL-21-secreting TFH cells in HIV-1-infected pregnant women (PW) than in non-pregnant patients (nPW). Moreover, in co-culture systems, CD4+ T cells from ART-treated PW were more efficient in assisting B cells to produce IgG production. The in vivo anti-HBsAg IgG titers after ARV therapy were also significantly higher in PW, and their levels were directly associated with both IL-21+ TFH frequency and plasma concentration of estrogen. CONCLUSION: In summary, our results suggest that pregnancy favors the recovery of TFH -like cells after ARV therapy in HIV-1-infected women, which could help these mothers to protect their newborns from infectious diseases by transferring IgG across the placenta.


Subject(s)
Anti-HIV Agents/pharmacology , HIV Infections/immunology , HIV-1 , Interleukins/metabolism , Pregnancy Complications, Infectious/immunology , T Follicular Helper Cells/metabolism , Adult , Anti-HIV Agents/therapeutic use , Antibodies, Bacterial/blood , Antibody Formation/drug effects , B-Lymphocytes/drug effects , CD4 Lymphocyte Count , Cells, Cultured , Coculture Techniques , Estrogens/blood , Female , HIV Antibodies/blood , HIV Envelope Protein gp41/immunology , HIV Infections/blood , HIV Infections/drug therapy , HIV-1/immunology , Hepatitis B Antibodies/blood , Hepatitis B Surface Antigens/immunology , Humans , Immunoglobulin G/blood , Pregnancy , Pregnancy Complications, Infectious/blood , Progesterone/blood , Tetanus Toxoid/immunology , Young Adult
12.
Clin Immunol ; 205: 93-105, 2019 08.
Article in English | MEDLINE | ID: mdl-31173888

ABSTRACT

Both obesity and low vitamin D levels have been associated with allergic asthma (AA) severity. In the present study, severity of AA was associated with obesity but to the in vitro IgE production. In those patients, higher levels of IL-5, IL-6 and IL-17 were quantified in CD4+ T-cell cultures as compared with patients with mild and moderate AA. In addition, the lowest IL-10 levels were detected in the cell cultures from patients with a worse prognosis. Interestingly, the occurrence of AA elevates the plasma levels of leptin, and this adipokine was positively correlated with the release of IL-5, IL-6 and IL-17, but inversely correlated with IL-10 production, by CD4+ T-cells from patients. In AA-derived CD4+ T-cell cultures, 1,25(OH)2D3 was less efficient at inhibiting IL-5, IL-6 and IL-17 production, and up regulating IL-10 release, as those from healthy subjects. Interestingly, the in vitro immunomodulatory effects of vitamin D were inversely correlated with serum leptin levels. In summary, our findings suggested that obesity, probably due to the overproduction of leptin, negatively impacts AA as it favors imbalance between Th2/Th17 and regulatory phenotypes. The deleterious effects of leptin may also be due to its ability to counter-regulate the immunosuppressive effects of vitamin D.


Subject(s)
Asthma/immunology , CD4-Positive T-Lymphocytes/immunology , Cytokines/immunology , Hypersensitivity/immunology , Leptin/metabolism , Obesity/metabolism , Adult , Asthma/metabolism , CD4-Positive T-Lymphocytes/drug effects , Calcitriol/pharmacology , Cytokines/drug effects , Female , Humans , Hypersensitivity/metabolism , Immunoglobulin E/immunology , In Vitro Techniques , Interleukin-10/immunology , Interleukin-17/immunology , Interleukin-5/immunology , Interleukin-6/immunology , Male , Middle Aged , Severity of Illness Index , Th1 Cells/drug effects , Th1 Cells/immunology , Th17 Cells/drug effects , Th17 Cells/immunology , Vitamin D/metabolism , Vitamins/pharmacology , Young Adult
13.
Dalton Trans ; 48(16): 5243-5252, 2019 Apr 16.
Article in English | MEDLINE | ID: mdl-30924489

ABSTRACT

The new bisamido aluminum species [AlCl{N(SiMe3)2}2(THF)] (1) was prepared and fully characterized by 27Al and 35Cl solid-state NMR, along with X-ray diffraction studies. 1 was grafted on silica partially dehydroxylated at 700 °C, affording silica-supported Al species. The resulting material (2) was characterized by IR, elemental analysis and 1H, 13C and 27Al solid-state MAS NMR. The 1D and 2D 27Al MAS NMR studies showed the occurrence of two types of species, where the Al center adopts a tetracoordinated coordination sphere, with as an additional coordinated Lewis base, either a THF ligand or a silica-surface siloxane moiety. DFT calculations allowed understanding the grafting mechanism and the spectroscopic properties of the material.

14.
Behav Sleep Med ; 17(4): 388-397, 2019.
Article in English | MEDLINE | ID: mdl-28929803

ABSTRACT

Objective: This study aimed to establish the determinants of perceived sleep quality over a longer period of time, taking into account the separate contributions of actigraphy-based sleep measures and self-reported sleep indices. Methods: Fifty participants (52 ± 6.6 years; 27 females) completed two consecutive weeks of home monitoring, during which they kept a sleep-wake diary while their sleep was monitored using a wrist-worn actigraph. The diary included questions on perceived sleep quality, sleep-wake information, and additional factors such as well-being and stress. The data were analyzed using multilevel models to compare a model that included only actigraphy-based sleep measures (model Acti) to a model that included only self-reported sleep measures to explain perceived sleep quality (model Self). In addition, a model based on the self-reported sleep measures and extended with nonsleep-related factors was analyzed to find the most significant determinants of perceived sleep quality (model Extended). Results: Self-reported sleep measures (model Self) explained 61% of the total variance, while actigraphy-based sleep measures (model Acti) only accounted for 41% of the perceived sleep quality. The main predictors in the self-reported model were number of awakenings during the night, sleep onset latency, and wake time after sleep onset. In the extended model, the number of awakenings during the night and total sleep time of the previous night were the strongest determinants of perceived sleep quality, with 64% of the variance explained. Conclusion: In our cohort, perceived sleep quality was mainly determined by self-reported sleep measures and less by actigraphy-based sleep indices. These data further stress the importance of taking multiple nights into account when trying to understand perceived sleep quality.


Subject(s)
Actigraphy , Self Report , Sleep/physiology , Adult , Aged , Cohort Studies , Female , Humans , Male , Middle Aged
15.
Enzyme Microb Technol ; 120: 77-83, 2019 Jan.
Article in English | MEDLINE | ID: mdl-30396402

ABSTRACT

We present a new heterogeneous biocatalyst based on the grafting of Bilirubin Oxidase from Bacillus pumilus into macrocellular Si(HIPE) materials dedicated to water treatment. Due to the host intrinsic high porosity and monolithic character, on-line catalytic process is reached. We thus used this biocatalyst toward uni-axial flux decolorizations of Congo Red and Remazol Brilliant Blue (RBBR) at two different pH (4 and 8.2), both in presence or absence of redox mediator. In absence of redox mediators, 40% decolorization efficiency was reached within 24 h at pH 4 for Congo Red and 80% for RBBR at pH 8.2 in 24 h. In presence of 10µM ABTS, it respectively attained 100% efficiency after 2h and 12h. We have also demonstrated that non-toxic species were generated upon dyes decolorization. These results show that unlike laccases, this new biocatalyst exhibits excellent decolorization properties over a wide range of pH. Beyond, this enzymatic-based heterogeneous catalyst can be reused during two months being simply stored at room temperature while maintaining its decolorization efficiency. This study shows that this biocatalyst is a promising and robust candidate toward wastewater treatments, both in acidic and alkaline conditions where in the latter efficient decolorization strategies were still missing.


Subject(s)
Bacillus pumilus/enzymology , Biodegradation, Environmental , Coloring Agents/chemistry , Coloring Agents/metabolism , Oxidoreductases Acting on CH-CH Group Donors/metabolism , Silicon Dioxide/chemistry , Catalysis , Online Systems , Oxidation-Reduction
16.
ChemSusChem ; 11(22): 3917-3922, 2018 Nov 23.
Article in English | MEDLINE | ID: mdl-30270516

ABSTRACT

An efficient carbonylative coupling reaction of two equivalents of 1,3-butadiene, yielding aryl nona-3,8-dienoate esters, is performed with phenols as nucleophile, and promoted by palladium-based catalysts. Optimization study reveals the key role of benzoic acid as a cocatalyst. The suggested catalyst combination enables the conversion of a wide scope of variously substituted phenols into corresponding esters with a high yield. Further tests were performed with diphenols, naturally-occurring phenols and an industrial grade Kraft lignin, thus, indicating the scope of this reaction for transforming industrially relevant polyphenolic structures.

17.
J Am Chem Soc ; 140(42): 13854-13868, 2018 10 24.
Article in English | MEDLINE | ID: mdl-30269503

ABSTRACT

Inorganic oxides play a crucial role in the activation of atomically dispersed metal oxides for catalytic olefin transformations, but the inefficient activation processes remain poorly understood. Activation of methyltrioxorhenium (MTO) for propene metathesis via its deposition on the surface of γ-Al2O3 typically results in <5% active sites, and these sites deactivate rapidly. Simple substitution of the support by a less crystalline (largely amorphous) alumina ( a-Al2O3) results in ca. 4× more activity and at least 10× more productivity. On both types of alumina, metathesis is initiated only at specific sites, whose availability limits the catalytic activity. While the two aluminas have similar total numbers of Lewis acid sites, the less crystalline support activates twice as many grafted MTO sites. Interestingly, a-Al2O3 has nearly double the number of strong Lewis acid sites. However, the number of active sites is ca. 10× lower than the total number of strong Lewis acid sites, and metathesis proceeds even when most are occupied by pyridine. DQSQ and D-HMQC 1H and 27Al solid-state NMR reveal that many Lewis acid sites are co-located with surface hydroxyl groups, which prevent activation and/or cause rapid deactivation. Undercoordinated Al sites on dominant (110) facets, which retain hydroxyl groups under catalyst preparation conditions, are therefore unlikely to lead to stable active sites. In contrast, the minor (100) facets of γ-Al2O3, which are completely dehydroxylated, contain strongly Lewis-acidic five-coordinate Al sites that are necessarily remote from surface hydroxyl groups. Such sites, which are relatively more abundant on less well-crystallized aluminas, are inferred to be responsible for generating stable metathesis sites.

18.
Eur J Immunol ; 48(8): 1376-1388, 2018 08.
Article in English | MEDLINE | ID: mdl-29719048

ABSTRACT

Excessive levels of proinflammatory cytokines in the CNS are associated with reduced serotonin (5-HT) synthesis, a neurotransmitter with diverse immune effects. In this study, we evaluated the ability of exogenous 5-HT to modulate the T-cell behavior of patients with MS, a demyelinating autoimmune disease mediated by Th1 and Th17 cytokines. Here, 5-HT attenuated, in vitro, T-cell proliferation and Th1 and Th17 cytokines production in cell cultures from MS patients. Additionally, 5-HT reduced IFN-γ and IL-17 release by CD8+ T cells. By contrast, 5-HT increased IL-10 production by CD4+ T cells from MS patients. A more accurate analysis of these IL-10-secreting CD4+ T cells revealed that 5-HT favors the expansion of FoxP3+ CD39+ regulatory T cells (Tregs) and type 1 regulatory T cells. Notably, this neurotransmitter also elevated the frequency of Treg17 cells, a novel regulatory T-cell subset. The effect of 5-HT in upregulating CD39+ Treg and Treg17 cells was inversely correlated with the number of active brain lesions. Finally, in addition to directly reducing cytokine production by purified Th1 and Th17 cells, 5-HT enhanced in vitro Treg function. In summary, our data suggest that serotonin may play a protective role in the pathogenesis of MS.


Subject(s)
Interferon-gamma/metabolism , Interleukin-17/metabolism , Multiple Sclerosis/pathology , Serotonin/metabolism , T-Lymphocytes, Regulatory/immunology , Th1 Cells/immunology , Th17 Cells/immunology , Adult , Brain/pathology , CD8-Positive T-Lymphocytes/immunology , Cell Proliferation/physiology , Cells, Cultured , Female , Humans , Lymphocyte Activation/immunology , Male , Multiple Sclerosis/immunology
19.
ChemSusChem ; 11(10): 1649-1655, 2018 May 25.
Article in English | MEDLINE | ID: mdl-29624897

ABSTRACT

Kraft lignin was efficiently functionalized with octadienyl ether linkages through the palladium-catalyzed telomerization of 1,3-butadiene. Comparison with molecular model substrates assessed the grafting of phenols and alcohols and an optimization study led to up to 69 % conversion of the total number of hydroxyl groups present in lignin. This catalytic study evidenced the partial oxidation of triphenylphosphine into triphenylphosphine oxide and triphenylphosphine sulfide by contaminants present in the industrial grade kraft lignin. The telomerised lignin is a malleable material and a preliminary study of the thermal properties showed a decrease in the glass transition in comparison with the starting material.

20.
PLoS Med ; 14(10): e1002402, 2017 Oct.
Article in English | MEDLINE | ID: mdl-28985239

ABSTRACT

BACKGROUND: The rVSVΔG-ZEBOV-GP vaccine prevented Ebola virus disease when used at 2 × 107 plaque-forming units (PFU) in a trial in Guinea. This study provides further safety and immunogenicity data. METHODS AND FINDINGS: A randomised, open-label phase I trial in Lambaréné, Gabon, studied 5 single intramuscular vaccine doses of 3 × 103, 3 × 104, 3 × 105, 3 × 106, or 2 × 107 PFU in 115 adults and a dose of 2 × 107 PFU in 20 adolescents and 20 children. The primary objective was safety and tolerability 28 days post-injection. Immunogenicity, viraemia, and shedding post-vaccination were evaluated as secondary objectives. In adults, mild-to-moderate adverse events were frequent, but there were no serious or severe adverse events related to vaccination. Before vaccination, Zaire Ebola virus (ZEBOV)-glycoprotein (GP)-specific and ZEBOV antibodies were detected in 11% and 27% of adults, respectively. In adults, 74%-100% of individuals who received a dose 3 × 104, 3 × 105, 3 × 106, or 2 × 107 PFU had a ≥4.0-fold increase in geometric mean titres (GMTs) of ZEBOV-GP-specific antibodies at day 28, reaching GMTs of 489 (95% CI: 264-908), 556 (95% CI: 280-1,101), 1,245 (95% CI: 899-1,724), and 1,503 (95% CI: 931-2,426), respectively. Twenty-two percent of adults had a ≥4-fold increase of ZEBOV antibodies, with GMTs at day 28 of 1,015 (647-1,591), 1,887 (1,154-3,085), 1,445 (1,013-2,062), and 3,958 (2,249-6,967) for the same doses, respectively. These antibodies persisted up to day 180 for doses ≥3 × 105 PFU. Adults with antibodies before vaccination had higher GMTs throughout. Neutralising antibodies were detected in more than 50% of participants at doses ≥3 × 105 PFU. As in adults, no serious or severe adverse events related to vaccine occurred in adolescents or children. At day 2, vaccine RNA titres were higher for adolescents and children than adults. At day 7, 78% of adolescents and 35% of children had recombinant vesicular stomatitis virus RNA detectable in saliva. The vaccine induced high GMTs of ZEBOV-GP-specific antibodies at day 28 in adolescents, 1,428 (95% CI: 1,025-1,989), and children, 1,620 (95% CI: 806-3,259), and in both groups antibody titres increased up to day 180. The absence of a control group, lack of stratification for baseline antibody status, and imbalances in male/female ratio are the main limitations of this study. CONCLUSIONS: Our data confirm the acceptable safety and immunogenicity profile of the 2 × 107 PFU dose in adults and support consideration of lower doses for paediatric populations and those who request boosting. TRIAL REGISTRATION: Pan African Clinical Trials Registry PACTR201411000919191.


Subject(s)
Adaptive Immunity/drug effects , Ebola Vaccines/administration & dosage , Ebolavirus/immunology , Hemorrhagic Fever, Ebola/prevention & control , Immunogenicity, Vaccine , Adolescent , Adult , Age Factors , Antibodies, Neutralizing/blood , Antibodies, Viral/blood , Biomarkers/blood , Child , Ebola Vaccines/adverse effects , Ebola Vaccines/immunology , Female , Gabon , Hemorrhagic Fever, Ebola/diagnosis , Hemorrhagic Fever, Ebola/immunology , Hemorrhagic Fever, Ebola/virology , Humans , Injections, Intramuscular , Male , Middle Aged , Time Factors , Treatment Outcome , Vaccination , Virus Shedding , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...